Evidence map›Paper›PMID 15673753›Full record

ArticleAntimicrobial agents and chemotherapy2005

Prevalence and subtypes of ciprofloxacin-resistant Campylobacter spp. in commercial poultry flocks before, during, and after treatment with fluoroquinolones.

Tom J Humphrey, Frieda Jørgensen, Jennifer A Frost, Haddy Wadda, Gil Domingue, Nicola C Elviss, Deborah J Griggs, Laura J V Piddock

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Antimicrobial resistance: Past, present, and way forward.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Whole Resistome Analysis inFrontiers in microbiology · 2021
    Article
  10. Prevalence ofFrontiers in microbiology · 2021
    Article
  11. Article
  12. Article
  13. Antibiotic resistance: a rundown of a global crisis.Infection and drug resistance · 2018
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Tom J HumphreySchool of Clinical Veterinary Science, University of Bristol, Langford, United Kingdom.
Frieda Jørgensen
Jennifer A Frost
Haddy Wadda
Gil Domingue
Nicola C Elviss
Deborah J Griggs
Laura J V Piddock
Health Protection Agency · MVUniversity of Birmingham · GBUniversity of Bristol · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five commercial broiler chicken flocks were treated with either difloxacin or enrofloxacin for a clinically relevant infection, as instructed by a veterinarian. Campylobacters were isolated from individual fecal samples and from samples associated with the broiler environment before, during, and after treatment. Ciprofloxacin-resistant Campylobacter jejuni and/or C. coli strains were detected pretreatment in four flocks, but they constituted a very small proportion of the campylobacters present. When the broilers were treated with a fluoroquinolone, a rapid increase in the proportion of ciprofloxacin-resistant campylobacters was observed. During treatment nearly 100% of campylobacters were resistant, and in some flocks a high proportion of resistant strains persisted for up to 4 weeks after treatment. Prior to treatment a variety of campylobacter subtypes were present. During and after treatment considerable changes in both species and subtype prevalence were observed, but no single fluoroquinolone-resistant clone became dominant. Instead, resistant C. coli strains or a mixture of resistant C. coli and C. jejuni strains became dominant, whereas susceptible C. jejuni strains had usually been dominant prior to treatment. The resistant subtypes which emerged and became dominant were not always the same as those detected pretreatment. The persistence of resistant strains for up to 4 weeks posttreatment has important implications for any strategy designed to avoid the introduction of such strains into the food chain.

Indexed as

AnimalsAnti-Bacterial AgentsBacteriophage TypingCampylobacterCampylobacter InfectionsCampylobacter jejuniChickensCiprofloxacinColony Count, MicrobialDrug Resistance, BacterialEscherichia coliFecesFluoroquinolonesPoultry DiseasesSerotypingUnited KingdomAnti-Bacterial AgentsCiprofloxacinFluoroquinolones

Identifiers

PMID15673753
PMCPMC547194
OpenAlexW2148437824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.